Flashcell

FLASHCELL, spin-off of Vectalys, is a private gene therapy company specialized in the development of therapeutic programs using the LentiFlash® technology. LentiFlash® is a game-changing class of RNA carriers based on a chimeric lentiviral particles leading to a transient RNA delivery and a short-term RNA expression into any cell type or tissue. FlashCell develops standalone gene-editing strategies in the fields of blood and hepatic diseases. Based on the licensed Vectalys’ LentiFlash® technology, FlashCell is committed to developing partnerships and licensing agreements with pharmaceutical, biotechnological companies and academics for therapeutic utilization of LentiFlash® delivery system. FlashCell provides its expertise and platform in cell engineering and vector manufacturing from R&D to GMP.